NANOVIRICIDES INC (NNVC) Stock Price, Quote, News and Overview
NYSEARCA:NNVC - NYSE Arca - US6300873022 - Common Stock - Currency: USD
NNVC Quote, Performance and Key Statistics
1.46
+0.05 (+3.55%)
The current stock price of NNVC is 1.46 USD. In the past month the price increased by 12.31%. In the past year, price decreased by -34.53%.
NNVC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.08 | 328.52B | ||
| AMGN | AMGEN INC | 13.29 | 148.31B | ||
| GILD | GILEAD SCIENCES INC | 13.72 | 132.17B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 113.28B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.46 | 64.41B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 37.97B | ||
| ARGX | ARGENX SE - ADR | 98.48 | 35.30B | ||
| ONC | BEIGENE LTD-ADR | 5.8 | 25.15B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.51B | ||
| NTRA | NATERA INC | N/A | 20.84B | ||
| BIIB | BIOGEN INC | 8.18 | 18.97B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.83B |
Related stock screener links
About NNVC
Company Profile
NanoViricides, Inc. is a clinical stage company, which engages in the development of nanomedicine drugs against viruses. The company is headquartered in Shelton, Connecticut and currently employs 7 full-time employees. The company went IPO on 2004-08-12. Its nanoviricide class of drug candidates and the nanoviricide technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. Its lead drug candidate is NV-387, a broad-spectrum antiviral drug that it plans to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. The company is focused on advancing NV-387 into Phase II human clinical trials. Its other advanced drug candidate is NV-HHV-1 for the treatment of Shingles. NV-CoV-2 (API NV-387) is its nanoviricide drug candidate for COVID-19 that does not encapsulate remdesivir. NV-CoV-2-R is its other drug candidate for COVID-19 that is made up of NV-387 with remdesivir encapsulated within its polymeric micelles. The company has developed both of its own drug candidates NV-CoV-2 and NV-CoV-2-R independently.
Company Info
NANOVIRICIDES INC
1 Controls Drive
Shelton CONNECTICUT 06484 US
CEO: Anil Diwan
Employees: 7
Phone: 12039376137
NANOVIRICIDES INC / NNVC FAQ
What is the stock price of NANOVIRICIDES INC today?
The current stock price of NNVC is 1.46 USD. The price increased by 3.55% in the last trading session.
What is the ticker symbol for NANOVIRICIDES INC stock?
The exchange symbol of NANOVIRICIDES INC is NNVC and it is listed on the NYSE Arca exchange.
On which exchange is NNVC stock listed?
NNVC stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for NANOVIRICIDES INC stock?
7 analysts have analysed NNVC and the average price target is 6.63 USD. This implies a price increase of 354.11% is expected in the next year compared to the current price of 1.46. Check the NANOVIRICIDES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NANOVIRICIDES INC worth?
NANOVIRICIDES INC (NNVC) has a market capitalization of 22.83M USD. This makes NNVC a Nano Cap stock.
How many employees does NANOVIRICIDES INC have?
NANOVIRICIDES INC (NNVC) currently has 7 employees.
What are the support and resistance levels for NANOVIRICIDES INC (NNVC) stock?
NANOVIRICIDES INC (NNVC) has a support level at 1.33 and a resistance level at 1.5. Check the full technical report for a detailed analysis of NNVC support and resistance levels.
Should I buy NANOVIRICIDES INC (NNVC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NNVC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NNVC, evaluating the profitability, health, valuation and growth aspects
- NANOVIRICIDES INC (NNVC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NANOVIRICIDES INC (NNVC) Sales and EPS estimates to see what analysts future expectations are.
- NANOVIRICIDES INC (NNVC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NANOVIRICIDES INC (NNVC) Insider and Institutional Ownership to learn about the owners and their transactions.
- NANOVIRICIDES INC (NNVC) Stock Chart to make your own analysis
- NANOVIRICIDES INC (NNVC) Latest news and press-releases to stay up to date.
Does NANOVIRICIDES INC (NNVC) stock pay dividends?
NNVC does not pay a dividend.
When does NANOVIRICIDES INC (NNVC) report earnings?
NANOVIRICIDES INC (NNVC) will report earnings on 2025-09-25, before the market open.
What is the Price/Earnings (PE) ratio of NANOVIRICIDES INC (NNVC)?
NANOVIRICIDES INC (NNVC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.72).
What is the Short Interest ratio of NANOVIRICIDES INC (NNVC) stock?
The outstanding short interest for NANOVIRICIDES INC (NNVC) is 0.87% of its float. Check the ownership tab for more information on the NNVC short interest.
NNVC Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to NNVC. When comparing the yearly performance of all stocks, NNVC is a bad performer in the overall market: 80.37% of all stocks are doing better.
NNVC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NNVC. While NNVC seems to be doing ok healthwise, there are quite some concerns on its profitability.
NNVC Financial Highlights
Over the last trailing twelve months NNVC reported a non-GAAP Earnings per Share(EPS) of -0.72. The EPS increased by 11.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -80.94% | ||
| ROE | -90.16% | ||
| Debt/Equity | 0 |
NNVC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to NNVC. The Buy consensus is the average rating of analysts ratings from 7 analysts.